Titre : | Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) |
Auteurs : | OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS |
Type de document : | Rapport |
Editeur : | Lisbon : OEDT / EMCDDA, 2020 |
Collection : | Risk assessments, ISSN 1725-4493 |
Format : | 55 p. |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus Géographique EUROPEThésaurus TOXIBASE OPIOIDES ; ANALGESIQUES ; PHENOMENE EMERGENT ; FACTEUR DE RISQUE ; SURVEILLANCE EPIDEMIOLOGIQUE ; CHIMIE ; PHARMACOLOGIE ; TOXICOLOGIEOrganismes OEDT |
Résumé : | This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on 26 May 2020. On the basis of the Risk Assessment Report, on 2 September 2020, the Commission decided that isotonitazene should be included in the definition of 'drug', in the Annex to Framework Decision 2004/757/JHA. Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with Commission Delegated Directive (EU) 2020/1687 by 3 June 2021. |
Domaine : | Autres substances / Other substances |
Affiliation : | EMCDDA, Lisbon, Portugal ; iKem BT, Budapest, Hungary |
Lien : | https://www.emcdda.europa.eu/publications/risk-assessments/isotonitazene_en |
Titre précédent : |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Documents numériques (1)
![]() ![]() EMCDDA_Risk-Assessment_Isotonitazene_2020 Adobe Acrobat PDF |
